Remove 2022 Remove Cell Biology Remove Pharmaceuticals Remove Pharmacokinetics
article thumbnail

Breakthrough drug candidates and cancer treatment innovations

Drug Target Review

It also displayed favourable pharmacokinetics (PK) and is well tolerated in non-human primates (NHP) at exposure levels above those projected to be efficacious. ZW191 also displayed favourable pharmacokinetics (PK) and is well tolerated in non-human primates (NHP) at exposure levels above those projected to be efficacious.

Treatment 100
article thumbnail

Advanced 3D cell-based technologies

Drug Target Review

1,2 This miniature organ chip devices emulate 3D structures with tissue-specific cell types and recreating organ functional units in an in vitro setting to test the effects of drugs and detailed reviewed. From 3D cell culture to organs-on-chips. Trends in Cell Biology. Reconstituting Organ-Level Lung Functions on a Chip.

article thumbnail

TACACICLIB, AUR-102, AURIGENE

New Drug Approvals

As such, it has been proposed that inhibiting CDK7 would provide a potent means of inhibiting cell cycle progression, which may be especially relevant given that there is compelling evidence from gene knockout studies in mice for lack of an absolute requirement for CDK2, CDK4 and CDK6 for the cell cycle at least in most cell types (M alumbres et al.,